|COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring.|
Semantics\sqcap Scalability\models\bot? Are Semantics and Scalability Incompatible?
If you have a question about this talk, please contact Microsoft Research Cambridge Talks Admins.
This event may be recorded and made available internally or externally via http://research.microsoft.com. Microsoft will own the copyright of any recordings made. If you do not wish to have your image/voice recorded please consider this before attending
So called “Semantic Technologies” are rapidly becoming mainstream technologies, with RDF and OWL now being deployed in diverse application domains, and with major technology vendors starting to augment their existing systems accordingly. This is, however, only the first step for Semantic Web research; we need to demonstrate that the Semantic Technologies we are developing can (be made to) exhibit robust scalability if deployments in large scale applications are to be successful. In this talk I will review the evolution of Semantic Technologies to date, and show how research ideas from logic based knowledge representation developed into a mainstream technology. I will then go on to examine the scalability challenges arising from deployment in large scale applications, and discuss ongoing research aimed at addressing them.
This talk is part of the Microsoft Research Machine Learning and Perception Seminars series.
This talk is included in these lists:
Note that ex-directory lists are not shown.
Other listsEPRG Public Events Whipple Museum of the History of Science Computer Modelling in Biology
Other talksReporting from Extreme Environments Multidimensional IRT models and their applications to psychological testing arty politics, capital mobilization and the rise of ‘small boys’ capitalists in Ghana’s Fourth Republic Exploring the Universe with Gravitational Waves: LIGO and Beyond Fertility Marketing and "Consumer Self-Spectacularisation" "There's something wrong with my MAM; the ER-mitochondria axis and neurodegenerative diseases"